GlassScriptPhysician profile
Jason Sanders
NPI 1619946738
$4,018.08
in general payments reported to CMS, 2019-2025
20 companies · $709 in 2025
The $709 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $434 · 2021: $190 · 2022: $662 · 2023: $812 · 2024: $834 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $903.75 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $529.69 | 2022-2025 | Syfovre |
| Genentech USA, INC. | $483.86 | 2019-2024 | Vabysmo |
| Astellas Pharma US INC | $430.22 | 2023-2025 | Izervay |
| Notal Vision, INC. | $301.65 | 2024-2025 | Foresee Home |
| Abbvie INC. | $219.60 | 2022-2025 | Ozurdex |
| Alimera Sciences, INC. | $184.29 | 2019-2023 | Iluvien |
| Mallinckrodt Hospital Products INC. | $180.92 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $173.76 | 2019-2021 | |
| Harrow Eye, LLC | $133.59 | 2025 | Iheezo |
| Horizon Therapeutics Plc | $123.69 | 2023 | Tepezza |
| Bausch & Lomb Americas INC. | $87.38 | 2022-2023 | Xipere, Visudyne, Retisert |
| Allergan, INC. | $62.31 | 2019-2020 | |
| Coherus Oncology, INC. | $58.78 | 2022-2023 | |
| Biogen, INC. | $47.27 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $25.79 | 2024 | Cimerli |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Spark Therapeutics, INC. | $18.66 | 2019 | |
| Eyepoint US, INC. | $17.71 | 2022 | |
| Alcon Vision LLC | $15.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.